News

Regeneron Pharmaceuticals said earlier this month that it will acquire “substantially all” of 23andMe’s assets for $256 million.
The company has started to add bearish views on Wall Street as the healthcare giant's business practices draw public scrutiny, risking its prospects, worsened by its recent leadership change. Bank of ...
Chris Zaetta currently works at UnitedHealth Group, Inc., as Secretary, Chief Legal Officer & Executive VP from 2024. Mr. Zaetta also formerly worked at Optum, Inc., as Chief Legal Officer from 2020 ...
UnitedHealth Group allegedly made secret bonus payments to nursing homes to cut costs by reducing hospital transfers, ...
Experts say it’s no surprise that UnitedHealthcare often ends up in the crosshairs of public and political scrutiny, as it’s ...
Following the sudden departure of its CEO, the health insurer is now facing an employee lawsuit, alleging UnitedHealth ...
On May 13, UnitedHealth Group (NYSE: UNH) suspended its 2025 outlook and announced the immediate departure of CEO Andrew Witty. On May 15, shares of America's leading health insurance benefits ...
UnitedHealth Group announced a surprise CEO transition on May 13. Shares of the integrated health insurance business are down by more than half from the all-time high it reached last year.
Civil investigations into Medicare billing practices at the company's physician offices. Antitrust investigations for possible violations in the healthcare marketplace. Business model: Medicare ...
BOSTON, May 16, 2025 (GLOBE NEWSWIRE) -- Block & Leviton is investigating UnitedHealth Group Incorporated (NYSE: UNH) for potential securities law violations. Investors who have lost money in ...
UnitedHealth Group said a recent media report that the Department of Justice launched a criminal investigation into the embattled company is false. The Wall Street Journal report, citing unnamed ...
Shares of UnitedHealth Group plunged more than 13% on Thursday following a report that the Department of Justice is conducting a criminal investigation into the health-care giant over possible ...